Healthcare Triangle AI Stock Analysis
Want to see HCTI full AI Analyst Report?
Healthcare Triangle (HCTI) AI Stock Analysis
Healthcare Triangle
(NASDAQ:HCTI)
Persistent losses and cash burn are the dominant risks, reinforced by very weak technical trends and an unfavorable earnings-based valuation. Nasdaq delisting uncertainty further weighs on the score, while revenue growth, improved equity, and the planned spin-off provide only limited support.
Healthcare Triangle (HCTI) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $2.80M
- Dividend Yield
- ―
- Average Volume (3M)
- 104.60K
- Price to Earnings (P/E)
- -0.0
- Beta (1Y)
- 1.48
- Revenue Growth
- 116.40%
- EPS Growth
- 99.31%
- Country
- US
- Employees
- 40
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Healthcare Information Services
Healthcare Triangle Business Overview & Revenue Model
Company Description
Healthcare Triangle, Inc. (HCTI) is a technology firm dedicated to the healthcare sector, specializing in crafting innovative solutions across cloud services, data science, and professional and managed IT support. The company provides a comprehensive...
How the Company Makes Money
HCTI primarily makes money by delivering services and solutions to healthcare and life-sciences customers under commercial agreements. Key revenue streams include: (1) Professional services/implementation revenue from project-based work such as cloud...
Healthcare Triangle Financial Statement Overview
Summary
Revenue growth and improved equity are outweighed by deeply negative margins, persistent net losses, and consistently negative operating and free cash flow.
Income Statement
18Very NegativeBalance Sheet
42NeutralCash Flow
12Very Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.68M | 13.89M | 11.70M | 33.20M | 45.89M | 35.27M |
| Gross Profit | 4.72M | 1.89M | 2.89M | 6.78M | 11.29M | 10.52M |
| EBITDA | -14.66M | -8.20M | -3.85M | -6.12M | -10.70M | -3.94M |
| Net Income | -17.02M | -9.48M | -5.97M | -8.69M | -14.36M | -5.95M |
Balance Sheet | ||||||
| Total Assets | 73.64M | 22.74M | 1.96M | 6.86M | 13.26M | 24.61M |
| Cash, Cash Equivalents and Short-Term Investments | 1.91M | 7.63M | 20.00K | 1.23M | 1.34M | 1.77M |
| Total Debt | 13.00M | 10.74M | 2.65M | 3.88M | 2.69M | 3.45M |
| Total Liabilities | 24.63M | 12.79M | 7.08M | 8.25M | 7.22M | 8.48M |
| Stockholders Equity | 49.10M | 9.98M | -5.11M | -1.39M | 6.04M | 16.14M |
Cash Flow | ||||||
| Free Cash Flow | -23.66M | -16.52M | -1.08M | -2.16M | -6.49M | -10.24M |
| Operating Cash Flow | -16.11M | -16.52M | -1.08M | -2.15M | -5.35M | -7.11M |
| Investing Cash Flow | -10.39M | -1.75M | 0 | -12.00K | -1.13M | -7.63M |
| Financing Cash Flow | 25.15M | 25.88M | -133.00K | 2.06M | 6.06M | 15.11M |
Healthcare Triangle Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HCTI, the sentiment is Negative. The current price of 3.66 is below the 20-day moving average (MA) of 5.58, below the 50-day MA of 10.16, and below the 200-day MA of 47.00, indicating a bearish trend. The MACD of -1.93 indicates Negative momentum. The RSI at 26.68 is Positive, neither overbought nor oversold. The STOCH value of 10.80 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HCTI.
Healthcare Triangle Risk Analysis
Healthcare Triangle disclosed 43 risk factors in its most recent earnings report. Healthcare Triangle reported the most risks in the "Legal & Regulatory" category.
Latest Risks Added
1 New RiskHealthcare Triangle Peers Comparison
Overall Rating
WAY76Outperform
CCLD66Neutral
PHR66Neutral
EVH58Neutral
HCAT51Neutral- HCTI38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| WAY | 76Outperform | $5.41B | 39.98 | 3.41% | ― | 21.43% | 9.80% |
| CCLD | 66Neutral | $112.33M | 18.64 | 24.48% | ― | 14.86% | 214.99% |
| PHR | 66Neutral | $783.34M | 73.69 | 3.01% | ― | 12.93% | ― |
| EVH | 58Neutral | $539.51M | -1.10 | -129.54% | ― | 14.06% | -189.46% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| HCAT | 51Neutral | $103.57M | -0.54 | -128.24% | ― | -13.88% | -78.38% |
| HCTI | 38Underperform | $3.32M | -0.00 | -56.46% | ― | 116.40% | 99.31% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HCTI | Healthcare Triangle, Inc. | 3.66 | -2228.34 | -99.84% | |
| CCLD | Carecloud, Inc. | 2.42 | -0.69 | -22.19% | |
| EVH | Evolent Health Inc. | 4.90 | 1.03 | 26.61% | |
| PHR | Phreesia | 12.69 | -7.91 | -38.40% | |
| HCAT | Health Catalyst | 1.51 | -0.73 | -32.59% | |
| WAY | Waystar Holding Corp. | 27.99 | -6.30 | -18.37% |
Healthcare Triangle Corporate Events
Healthcare Triangle Enacts Reverse Split Amid Nasdaq Review
NegativeOn October 26, 2026, Healthcare Triangle, Inc. implemented a one-for-twenty reverse stock split of its common shares, consolidating approximately 17.73 million outstanding shares into about 886,000 shares while leaving authorized share capital unchan...
Healthcare Triangle Shareholders Approve Key Capital Changes
PositiveOn October 23, 2026, Healthcare Triangle, Inc. held a virtual special meeting of stockholders at which holders of about 53.69% of eligible shares were present or represented by proxy. Investors approved several capital structure and governance-relate...
Healthcare Triangle Faces Nasdaq Delisting After Bid-Price Breach
NegativeOn October 1, 2026, Healthcare Triangle, Inc. received a notice from Nasdaq’s Listing Qualifications Department stating that the company is not in compliance with the minimum $1.00 bid price requirement for continued listing on the Nasdaq Capital Mar...
Healthcare Triangle Amends Equity Funding Agreement Terms
NeutralOn September 22, 2026, Healthcare Triangle amended its June 12, 2026 equity purchase agreement with Hudson Global Ventures, adjusting key financing terms that govern how the company can raise capital through equity puts to the investor. The changes r...
Healthcare Triangle advances Teyame AI spin-off plans
PositiveOn September 2, 2026, Healthcare Triangle entered into a Separation and Distribution Agreement and a Transition Services Agreement with its subsidiary Teyame AI Holdings to execute a planned spin-off and public listing of Teyame. HCTI will distribute...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 06, 2026